دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Rheumatoid arthritis and atrial fibrillation: bridging the gap in ischaemic stroke prevention Free
doi : 10.1093/rheumatology/keae548
Volume 64, Issue 2, February 2025
Assessment of damage in Takayasu arteritis in the clinic: an idea whose time has come! Free
Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease Open Access
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease Open Access
Association of ankylosing spondylitis with the risk of cancer: a meta-analysis of cohort studies Free
Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review
Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA Open Access
Development and validation of a new tool for assessment of trainees’ interventional musculoskeletal ultrasound skills Free
Correlation between the oxygenation status of extrasynovial tissue in the wrist and disease activity in rheumatoid arthritis: a photoacoustic imaging study Free
Very-low-dose glucocorticoid therapy in rheumatoid arthritis: impact of b/tsDMARDs initiation timing on glucocorticoid withdrawal Free
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study Free
Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis Free
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: a STARTERÂ study post-hoc analysis Free
Disease activity–guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study Open Access
Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study Free
The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials Free
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel Open Access
Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity Free
Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat? Free
Comparative risk of incident and recurrent acute anterior uveitis across different biological agents in patients with ankylosing spondylitis Free
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study Free
Prognostic value of hypermetabolic bone sarcoidosis observed by 18F-fluorodeoxyglucose positron emission tomography Free
Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study Free
Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab Open Access
Association of disease activity with depression and anxiety in systemic lupus erythematosus: a comparison of SLEDAI-2K and SLE-DAS Free
Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up
Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment
Preliminary nomogram model for predicting irreversible organ damage of patients with systemic sclerosis Open Access
Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial Free
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis Free
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's Open Access
Associations between plasma metabolism-associated proteins and future development of giant cell arteritis: results from a prospective study Open Access
Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy Free
Follow-up ultrasound examination in patients with newly diagnosed giant cell arteritis Free
The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations Free
Diagnostic value of a novel salivary gland ultrasound scoring system in IgG4-related sialadenitis Free
Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis Free
Patient-reported outcome for physical function in idiopathic inflammatory myopathy Free
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement Open Access
Pain is common in myositis and associated with disease activity Free
Fragmented QRS complex could predict all-cause mortality in patients with connective tissue disease–associated pulmonary arterial hypertension Free
Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis Open Access
The emerging role of growth differentiation factor 15 as a potential disease biomarker in juvenile dermatomyositis Open Access
Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study Free
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings Open Access
Patient–physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation Free
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment Free
Seven-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls Open Access
High-resolution magnetic resonance imaging visualizes intracranial large artery involvement in giant cell arteritis Free
Interleukin-6 trans-signalling regulates monocyte chemoattractant protein-1 production in immune-mediated necrotizing myopathy Free
Transcriptomic profiling of osteoarthritis synovial macrophages reveals a tolerized phenotype compounded by a weak corticosteroid response Open Access
16s RNA-based metagenomics reveal previously unreported gut microbiota associated with reactive arthritis and undifferentiated peripheral spondyloarthritis Free
A new ex vivo human model of osteoarthritis cartilage calcification Open Access
Correction to: Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis Free
Correction to: Heliotrope-like rash in a febrile child: think of Kawasaki disease Free
Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis Open Access
Human umbilical cord mesenchymal stem cells treated anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a case report Free
A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement Free
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. Reply Open Access
Comment on: Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel Free
Heliotrope-like rash in a febrile child: think of Kawasaki disease Free
Involvement of erector spinae muscles in a case of systemic lupus erythematosus with anti-HMGCR antibody
